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Abstract
The cross-talk between ovarian cancer (OvCa) cells and the metastatic microenvironment is an 
essential determinant of successful colonization. Micro(mi)RNAs play several critical roles during 
metastasis; however, the role of microenvironmental cues in the regulation of miRNAs in 
metastasizing cancer cells has not been studied. Using a 3D culture model that mimics the human 
omentum, one of the principal sites of OvCa metastasis, we identified and characterized the 
microenvironment-induced downregulation of a tumor suppressor miRNA, miR-193b, in 
metastasizing OvCa cells. The direct interaction of the OvCa cells with mesothelial cells, which 
cover the surface of the omentum, caused a DNA methyltransferase 1 (DNMT1) mediated 
decrease in the expression of miR-193b. The reduction in miR-193b enabled the metastasizing 
cancer cells to invade and proliferate into human omental pieces ex vivo and into the omentum of 
a mouse xenograft model of OvCa metastasis. The functional effects of miR-193b were mediated, 
in large part, by the concomitant increased expression of its target, urokinase-type plasminogen 
activator (uPA), a known tumor-associated protease. These findings link paracrine signals from the 
microenvironment with the regulation of a key miRNA that is essential for the initial steps of 
OvCa metastatic colonization. Targeting miR-193b could prove effective in the treatment of OvCa 
metastasis.
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Introduction
Ovarian cancer (OvCa) rarely metastasizeshematogenously, and is generally confined to the 
peritoneal cavity1, 2. The cancer cells exfoliate from the primary tumor and are carried 
around the peritoneal cavity by the peritoneal fluid. One of the predominant sites of 
metastasis is the omentum, which is a large adipose-rich fold of the peritoneum that covers 
the bowels3. The key and rate limiting step for successful metastasis is the colonization of 
the metastatic organs following attachment of cancer cells4, 5. Most of our current 
knowledge of OvCa metastasis is derived from comparisons of the factors expressed in 
metastatic tumors with those in the primary tumor. Therefore, the regulation of the steps 
involved as the cancer cells spread from the primary tumor to the distant metastatic site is 
not well understood.
MicroRNAs(miRNA) have well known pleiotropic effects in cancer6 and a specific role in 
metastasis, which has recently begun to be explored (reviewed in7). In particular, studies 
have investigated the role of miRNAs in the regulation of processes that aid metastasis: 
miR-10b, miR-373 and miR-520c have been shown to promote invasion8, 9; miR-374a, 
miR-200, and miR-22 to induce EMT10, 11; and miR-126 was found to increase 
angiogenesis12. Recent reports have demonstrated that miRNAs are regulated by the cellular 
microenvironment13, 14. However, it is not yet clear whether miRNA changes in cancer cells 
that contribute to the initial colonization of distant metastatic sites arise independently, or if 
they are dependent on microenvironmental cues.
Given the bidirectional communication between the tumor-microenvironment and cancer 
cells15, we reasoned that mesothelial cells, the first cell type an OvCa cell encounters when 
metastasizing to tissues in the peritoneal cavity, could affect miRNA expression in OvCa 
cells. Using an organotypic 3D culture model that mimics the surface of the human 
peritoneum and omentum16, we examined how miRNAs regulateOvCametastatic 
colonization. We report here that the most downregulated miRNA, miR-193b, has a role in 
promoting omental colonization through the upregulation of its target urokinase (uPA) and 
that miR-193b is epigenetically repressed in cancer cells through their interactions with the 
mesothelial cells covering the surface of the omentum.
Results
miR-193b is the most downregulated miRNA in colonizing OvCa cells
An in vitro organotypic 3D culture system that mimics the surface of the human omentum 
was used to identify miRNAs that could potentially regulate early metastatic colonization16. 
The 3D culture system was assembled by seeding a confluent monolayer of human primary 
mesothelial cells (HPMC) over a layer of collagen I and normal omental fibroblasts (NOFs). 
HeyA8 OvCa cells expressing GFP were added to the 3D culture and sorted after 2 days by 
FACS (Fig. 1a). A miRNA array analysis was performed to compare miRNA expression 
levels of OvCa cells seeded on the 3D culture with those seeded on plastic (Fig. 1a). Since 
most miRNAs are globallydownregulated in OvCa17, we focused on miRNAs whose 
expression was further decreased in cancer cells when seeded on the 3D culture. The most 
downregulated miRNA was miR-193b (Fig. 1b). Since mesothelial cells cover the surface of 
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the entire abdominal cavity, including the omentum, and are the first cell type with which 
OvCa cancer cells interact as they metastasize18, 19, OvCa cells were seeded ona confluent 
monolayer of HPMCs and miRNA expression profiling was repeated (Supplementary Fig. 
1). Again, miR-193b was one of the 5 most downregulated miRNAs in HeyA8 cells seeded 
on HPMCs (Supplementary Table 1). These results were confirmed by qRT-PCR for 
miR-193b in 2 OvCa cell lines seeded on the 3D culture or on HPMCs (Fig. 1c). A similar 
decrease in the expression of miR-193b was also seen in primary OvCa cells obtained from 
patient ascites and in RKO1 colon cancer cells when seeded on the 3D culture 
(Supplementary Fig. 2a and c). To approximate the in vivo situation encountered by OvCa 
cells more closely, cells were seeded on pieces of full human omentum and cultured ex vivo 
for up to 7 days (Fig. 1d). At each time point, the cancer cells were isolated by enzymatic 
digestion followed by FACS to separate the fluorescently labeled OvCa cells. qPCR for 
miR-193b showed that miR-193b was decreased in HeyA8 cells colonizing the omentum for 
2 and 7 days (Fig. 1d), suggesting that the decrease was an early but sustained response to 
interactions with the microenvironment. We also compared the miR-193b expression levels 
in omental metastasis and the adjacent normal omentum in 7 high grade serous OvCa 
patients. miR-193b expression was significantly decreased in the metastatic tumors (Fig. 1e). 
Since adipocytes are a major constituent of the omentum, their effect on miR-193b 
expression in OvCa cells was tested by co-culturing Skov3ip1 cells with adipocytes isolated 
from human omentum. Co-culture with adipocytes had no effect on Skov3ip1 miR-193b 
expression (Supplementary Fig. 2b). These results suggest that miR-193b downregulation is 
an early event in omental colonization, and that interactions with mesothelial cells alone are 
sufficient to downregulate miR-193b expression in cancer cells.
miR-193b suppresses cancer cell growth and motility
Because miR-193b was downregulated during metastatic colonization, we studied the effect 
of overexpression or inhibition of miR-193b on OvCa cell growth, motility, invasiveness and 
adhesion. HeyA8 OvCa cells, made to stably overexpress miR-193b by lentiviral infection 
(Supplementary Fig. 3a), exhibited both reduced colony formation (Fig. 2a) and transwell 
migration (Fig. 2b). Similar results were obtained when Skov3ip1 and ES2 OvCa cells were 
transiently transfected with pre-miR-193b(Supplementary Fig. 4a-d). We also found that 
stable overexpression of miR-193b inhibited the ability of HeyA8 cells to attach to the 3D 
culture or to mesothelial cells (Fig. 2c) and impaired invasion through the 3D culture (Fig. 
2d). Conversely, transient transfection of HeyA8 cells with a miR-193b inhibitor (LNA anti-
miR-193b, Supplementary Fig. 3b) increased colony formation as well as migration (Fig. 2e 
and f). Similar results were obtained with Skov3ip1 cells (Supplementary Fig. 4e and f). In 
order to more realistically mimic the in vivo scenario found in patients, the role of miR-193b 
in cancer cells colonizing human omentum pieces ex vivo was investigated. HeyA8 cells 
stably expressing miR-193b and GFP were seeded on pieces of normal omentum in culture 
dishes and allowed to grow for 7 days (as described in Fig. 1d). The GFP-expressing cancer 
cells growing on the omentum were imaged with a fluorescent microscope, digested, and 
cancer cell growth was quantified by measuring fluorescence. Fluorescent imaging and H&E 
staining showed a decrease in the growth of the HeyA8 cells that stably expressed 
miR-193b, as compared to control vector. (Fig. 3a). To test the effect of the overexpression 
of miR-193b in vivo, an orthotopic xenograft mouse model of OvCa metastasis was used. 
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This model recapitulates the pattern of human OvCa metastasis, as evidenced by 
disseminated nodules on the peritoneum and omental metastasis20, 21. HeyA8 cells, stably 
expressing either miR-193b or the control vector, were injected intraperitoneally (i.p.) into 
female nude mice. Stable overexpression of miR-193b (Supplementary Fig. 5) decreased 
tumor burden by more than 50% in the mice (Fig. 3b). This decrease was paralleled by a 
significant reduction of proliferation in the miR-193b overexpressing tumors (Ki-67 
staining). The miR-193b tumors also had a greater rate of apoptosis, as evidenced by 
increased staining of cleaved caspase 3 in tumor sections (Fig. 3b). To determine the effect 
of miR-193b inhibition, HeyA8 cells stably expressing miR-Zip-193b, an inhibitor of 
miR-193b, or control vector, were injected i.p. in female nude mice (Fig. 3c). Inhibition of 
miR-193b resulted in a 1.6 fold increase in tumor weight, indicating that the decreased 
miR-193b activity promoted metastasis in vivo.
miR-193b is regulated by promoter hypermethylation during colonization
miRNAs are transcribed and subsequently undergo sequential nucleolytic processing in the 
nucleus and in the cytoplasm22. The miR-193b downregulation in the colonizing cancer cells 
could be due to decreased transcription or changes in post-transcriptional processing. To 
understand the effect of the microenvironment on miR-193b regulation, HeyA8 cells were 
grown on the 3D culture for 48 hours, RNA was extracted and primary miR-193b (pri-
miR-193b) levels were analyzed by Northern Blot. Figure 4a shows that pri-miR-193b was 
transcriptionally downregulated when the OvCa cells were seeded on the 3D culture. We 
tested the possibility that miR-193b was downregulated in OvCa through promoter 
hypermethylation induced by the interaction of OvCa cells with the microenvironment. 
Treatment of HeyA8 cells with the DNA methyltransferase (DNMT) inhibitor, 5-
aza-2′deoxycytidine (decitabine), led to re-expression of miR-193b when OvCa cells were 
seeded either on HPMCs or on the 3D culture (Fig. 4b), suggesting that miR-193b was 
downregulated by mesothelial cell-induced promoter hypermethylation. Expression of the 
three DNMT isoforms23 was characterized, using qPCR, in HeyA8 cells seeded on the 3D 
culture and on mesothelial cells. Only DNMT1 expression showed a statistically significant 
increase in both the HeyA8 cells grown on the 3D culture and on mesothelial cells 
(Supplementary Fig. 6). Silencing DNMT1 in HeyA8 cells (Supplementary Fig. 7a) and 
seeding them on the 3D culture increased their expression of miR-193b (Fig. 4c). Because 
DNMT1 may affect multiple genes, we sought to determine if silencing DNMT1 specifically 
reverses the functional effect of miR-193b inhibition in cancer cells. HeyA8 cells were 
transiently transfected with either aDNMT1 siRNA or anti-miR-193b, with both together, or 
with an equimolar amount of scrambled control oligomers, and then used in proliferation 
and migration assays. miR-193b inhibition resulted in increased proliferation (Fig. 4d) and 
migration (Fig. 4e) while DNMT1 knockdown decreased both proliferation (Fig. 4d) and 
migration (Fig. 4e). Co-transfection of anti-miR-193b and DNMT1 siRNA neutralized the 
effects of DNMT1 inhibition on both proliferation and migration (Fig. 4d and e), suggesting 
that DNMT1 modulates miR-193b transcription through promoter methylation.
miR-193b regulates the expression of urokinase-type plasminogen activator
We next endeavored to determine which target proteins are activated when miR-193b is 
downregulated during early metastasis. We first considered the urokinase-plasminogen 
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activator (uPA) because 1) we and others had previously identified uPA as a critical factor in 
the metastatic spread and progression of OvCa24, 25 and 2) uPA is a predicted miR-193b 
target by miRNA target prediction algorithms (TargetScan and microRNA.org/miRanda). 
uPA is a secreted serine protease which is upregulated in OvCa25, 26 and plays a role in 
enhancing the proliferation, migration and adhesion of cancer cells27. When HeyA8 or 
Skov3ip1 OvCa cells were seeded on the 3D culture, uPA protein expression was induced 
(Fig. 5a). The overexpression of miR-193b in HeyA8 cells inhibited uPA protein expression 
while inhibition of miR-193b resulted in an increase in uPA expression (Fig. 5b and 
Supplementary Fig. 8a), confirming that uPA is regulated by miR-193b in OvCa cells. To 
investigate the direct binding of miR-193b to its seed sequence in uPA 3′UTR, we used wild 
type and miR-193b seed match mutated human uPA 3′UTR constructs (Supplementary Fig. 
8b). Transfection of the wild type construct along with miR-193b inhibited luciferase 
activity, where as no inhibition was observed for the mutated uPA 3′UTR, indicating direct 
targeting of uPA by miR-193b (Fig. 5c). Subsequently, we investigated the possible role of 
uPA in mediating the functional effects of miR-193b in OvCa metastasis. HeyA8 cells were 
transfected with uPA siRNA (Supplementary Fig. 7b) and the effect of uPA knockdown was 
studied. Silencing uPA in HeyA8 cells resulted in decreased colony formation (Fig. 5d), 
transwell migration (Fig. 5e) and invasion through the 3D culture (Fig. 5f). It did not, 
however, have a significant effect on adhesion to the 3D culture (Fig. 5g). These results 
indicate that blocking uPA mimics most of the effects of miR-193b overexpression. We 
therefore reasoned that silencing uPA should abrogate most of the pro-tumorigenic effects of 
miR-193b inhibition. To this end, HeyA8 cells were transfected with either anti-miR-193b or 
uPA siRNA, or with both. Figure 5h shows that co-transfection of uPA siRNA with anti-
miR-193b abrogated the increase in migration due to miR-193b inhibition, suggesting that 
uPA is a mediator of the effects of miR-193b downregulation.
Discussion
miRNAs have been reported to play a role in the regulation of metastasis
miR-373 and miR-520c were identified as metastasis promoters by a genetic screen used to 
detect miRNAs that aid in the migration and invasion of breast cancer cells in vivo9. The 
downregulation of miR-31 was also found to promote metastasis through the simultaneous 
induction of several metastasis-promoting targets28. Whether colonization of the distant 
organ, which is a first and critical step in successful metastasis4, 29, 30, is regulated by 
miRNA (s) has not been previously explored because of a lack of suitable experimental 
models. In order to dissect out the early events in the process of colonization during OvCa 
metastasis, we used an organotypic 3D culture system that closely mimics the surface of the 
human omentum (reviewed by White et al31). By employing an unbiased miRNA array 
approach, we identified miR-193b as the most downregulated miRNA in colonizing OvCa 
cells.
miR-193b has been previously reported to act as a tumor suppressor in prostate cancer, acute 
myeloid leukemia and hepatocellular carcinoma32-34. Furthermore, a decrease in miR-193b 
has been found to promote breast cancer tumor progression through an increased expression 
of urokinase35. We have demonstrated, using a variety of models, that a reduction in 
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miR-193b expression in cancer cells facilitates the early steps of OvCa metastasis, while 
miR-193b overexpression curtails metastatic functions. We now provide the first report that 
the mesothelial cell mediated repression of miR-193b is critical for OvCa metastatic 
colonization and the subsequent early invasion of OvCa cells into the omentum (Fig. 5i). All 
OvCa cell lines examined, as well as short-term cultures of primary OvCa cells isolated 
from the ascites of patients with OvCa, and colon cancer cells showed decreased miR-193b 
expression when seeded on the 3D organotypic culture. Furthermore, miR-193b expression 
was found to be lower in the omental metastasis than in the adjacent normal omentum of 
patients with high grade serous OvCa, indicating that the metastatic process results in a 
sustained decrease in miR-193b expression. This was confirmed with a novel assay in which 
OvCa cells were seeded on organ cultures of full human omentum ex vivo. In this 
experiment, a decrease in miR-193b was maintained 7 days after the cancer cells were 
seeded, demonstrating that it is a sustained effect and not just an acute response. That this 
downregulation of miR-193b in OvCa cells is dependent on contact with mesothelial cells, is 
supported by our co-culture experiments of OvCa cells with the 3D culture or mesothelial 
cells. While the omental microenvironment harbors other cell types, most notably adipocytes 
and fibrobasts, further experiments demonstrated that neither adipocytes nor fibroblasts 
significantly affected miR-193b expression in OvCa cells. Although the co-culture of cancer 
cells with adipocytes was planned with the smallest amount of media allowing the different 
cell types to touch, the buoyant adipocytes might not completely replicate the more intimate 
cell-cell interactions in vivo. Therefore, we do not rule out the possible contribution of 
omental adipocytes to the miR-193b downregulation in the metastasizing cancer cells. 
Mesothelial cells, however, induced down-regulation of miR-193b in the cancer cells, 
resulting in a pronounced increase in biologic effects that include important first steps of 
abdominal metastasis; adhesion, invasion, migration, and colony formation. Conditioned 
medium from mesothelial cells did not alter miR-193b expression in the cancer cells (data 
not shown), indicating that juxtacrine interactions are probably involved in the cross-talk 
between OvCa and mesothelial cells. To the best of our knowledge, this is the first report 
showing that mesothelial cells directly regulate miRNA expression in cancer cells.
The sustained downregulation of miR-193b in OvCa cells, even after a short interaction with 
mesothelial cells, suggested a possible epigenetic regulation of miR-193b. Significantly, it 
has been demonstrated that miR-193b is downregulated in prostate cancer cells via 
hypermethylation of CpG islands in its promoter32. We found that pre-treatment of HeyA8 
cells with the DNMT inhibitor, decitabine, completely abrogated a decrease in miR-193b 
when the cancer cells were seeded on the 3D culture or on mesothelial cells. Our data further 
revealed that DNMT1 repressed miR-193b in OvCa cells cultured on mesothelial cells. 
Silencing DNMT1 in HeyA8 cells could abrogate the effects of miR-193b inhibition on their 
migration as well as proliferation, indicating a role for DNMT1 in miR-193b regulation. 
This is consistent with recent data showing that DNMTs are overexpressed in OvCa and 
regulated by activated EGFR36, 37. Moreover, HeyA8 OvCa cells have a three-fold higher 
expression of DNMT1 when compared to normal ovarian surface epithelial cells38. 
Although DNMT1 has a preference for hemi-methylated DNA, it can also act as a de novo 
methyltransferase, since it has greater specific activity than DNMT3A and DNMT3B23.
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The pro-colonizing effect of miR-193b loss is mediated, at least in part, by regulation of the 
serine protease uPA, consistent with reports that miR-193b directly targets uPA in breast and 
prostate cancer cells35, 39, 40. Urokinase has been shown to promotelung cancer cell invasion 
through the recruitment of integrins and ECM proteins into the uPA/uPA receptor 
complex41. In OvCa, uPA expression in serum or ascites is correlated with an adverse 
prognosis and inhibition of uPA by antibodies, siRNA or anti-sense oligonucleotides 
reduced metastasis in several preclinical models42, 43. Given that uPA mediates key tumor 
functions, the up-regulation of uPA as a consequence of miR-193b down-regulation during 
early metastasis is consistent with the identification of miR-193b as a tumor suppressor. 
Taken together, the data are consistent with a model in which mesothelial cell-induced 
downregulation of miR-193b facilitates metastatic colonization of OvCa cells through the 
increased expression of its target, uPA (Fig. 5i). These findings support the recent concept 
that the microenvironment is recruited by tumor cells to support critical functions required 
for metastasis14, 44.
Materials and methods
Reagents
Trypsin, Dulbecco's Modified Eagle Medium (DMEM), MEM vitamins, MEM nonessential 
amino acids and Penicillin-Streptomycin were purchased from Media Tech (Manassas, VA). 
TaqMan miRNA assay for hsa-miR-193b was obtained from Applied Biosystems (Foster 
City, CA). Pre-miR-193b, and scrambled pre-miR negative control were from Ambion 
(Austin, TX), miRCURY LNA anti-miR-193b and scrambled anti-miR negative control 
were from Exiqon (Vedbæk, Denmark). The lentivirus vector expressing copepod (c) GFP 
(CD511B-1) and pre-miR-193b, miR-Zip-193b microRNA inhibitor vector, the control 
vectorsand the lentivirus packaging kit (LV500A-1) were purchased from System 
Biosciences (Mountain View, CA). The DNMT inhibitor 5-Aza-2′-deoxycytidine 
(decitabine) was purchased from Sigma-Aldrich, St. Louis, MO (Cat# A3656). The siRNA's 
used were Dharmacon (Lafayette, CO) SMARTpool siRNAs: DNMT1 siRNA M-004605-01 
and siGENOME PLAU siRNA M-006000-02
Cell lines
The human OvCa cell lines Skov3ip1 (first described by Janet Price45) and HeyA8 were 
from Gordon B. Mills (M.D. Anderson Cancer Center, Houston, TX). Human OvCa cell 
lines HeyA8, Skov3ip1, and ES2 were validated by short tandem repeat (STR) DNA 
fingerprinting using the AmpFℓSTR Identifier kit (Applied Biosystems) and compared with 
known American Type Culture Collection fingerprints, the Cell Line Integrated Molecular 
Authentication database (CLIMA), and the University of Texas MD Anderson Cancer 
Center fingerprint database.
Isolation and culture of primary cells and assembly of the 3D culture
Primary human mesothelial cells (HPMC) and normal omental fibroblasts (NOF) were 
isolated as described previously16 from omentum obtained from female patients undergoing 
surgery for benign conditions at the University of Chicago. The primary cells were grown in 
DMEM with 10% FBS. HPMCs were used for experiments between passages 1 and 2 while 
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NOFs were used between 2 and 5. The 3D omental culture was assembled in 10 cm culture 
dishes by first seeding 360,000 NOFs along with 91μg of Collagen Type I (Rat tail, BD 
Cat#354236) in DMEM. After attachment, 3.6×106 HPMCs were seeded on top to form a 
confluent monolayer and the 3D culture was used 24 h later for experiments to investigate 
the initial events of colonization. GFP expressing OvCa cells (1×106) were seeded on the 3D 
culture and allowed to grow for 2 days. Cells were trypsinized and fluorescent cancer cells 
were isolated by fluorescence activated cell sorting (FACS) and used for RNA/protein 
isolation. The human omental adipocytes were isolated and co-cultured with OvCa cells, as 
described previously46. Briefly, Skov3ip1 cells (1 × 106) were seeded in 60mm dishes, 
incubated for 18 – 24 h, washed twice with PBS and 2.1 ml of DMEM/F12 media (1:1 ratio, 
containing 0.1% Fraction V, fatty-acid-free BSA) was added. 700μl (packed cell volume) of 
adipocytes was overlaid onto the Skov3ip1 cells, and co-cultured for 8 hours. Adipocytes 
were removed by aspiration and Skov3ip1 cells were washed 3 – 5 times with PBS. RNA 
was isolated using TRizol Reagent (Life Technologies, Grand Island, NY) and used for 
miR-193b qPCR. This research was approved by the Institutional Regulatory Board of the 
University of Chicago. To set up the 3D culture in transwell inserts or 96 well plates, the 
number of cells and the amount of collagen were proportionately reduced according to the 
growth surface area.
Omental metastasis and adjacent normal omentum samples
RNA was extracted from paired, fresh frozen samples of omental metastasis and adjacent 
normal omentum, obtained from 7 high grade serous OvCa patients. Briefly, tissue was 
homogenized using the TissueRuptor (Qiagen) and total RNA was extracted using the 
miRNeasy kit (Qiagen), according to the manufacturer's instructions. The miR-193b 
expression levels in these samples were assayed by qRT-PCR using a TaqMan assay 
(Applied Biosystems).
miRNA Array
Total RNA was isolated using the miRNeasy mini kit (Qiagen) according to the 
manufacturer's protocol and submitted to Exiqon for miRNA profiling using the miRCURY 
LNA array (v.10.0). First, all miRNAs that were not significantly expressed were eliminated. 
Thereafter, only those miRNAs with p-values ≤0.05 for HeyA8 cells seeded on 3D culture 
versus plastic were included in the analysis and were ranked according the fold change in 
expression.
Real-time PCR
Quantitative real-time–PCR (qPCR) for miR-193b was performed using TaqManmiRNA 
assay kit according to the manufacturer's protocol on the Prism7500 TaqMan qPCR machine 
(Applied Biosystems) with U6 or RNU48 as endogenous controls. Similarly, qPCR for uPA, 
DNMT1, DNMT3A and DNMT3B were carried outusing TaqMan gene expression assay 
(Applied Biosystems) using GAPDH as an endogenous control.
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Northern blotting
Total RNA (30μg) was separated by 1% agarose formaldehyde gel electrophoresis and 
transferred overnight to a nylon membrane (Hybond-N, GE Healthcare) by the capillary 
method. RNA was cross-linked to the membrane with UV and hybridized to 0.1nM double-
DIG labeled antisense miRCURY LNA probes against miR-193b (Exiqon). The membrane 
was probed with anti-DIG AP antibody (Roche, Cat#11093274910) and detected using 
chemiluminescence (Roche CDP-Star, Cat# 12041677001) which was imaged using a 
SyngeneG:Box imaging system.
Ex vivo culture of human omentum
Omental tissue, obtained from female patients undergoing surgery for benign conditions, 
was cut into pieces weighing 300 mg and cultured in DMEM containing 10% FBS in 6 well 
dishes. GFP-expressing HeyA8 cells were added to the omentum pieces and allowed to 
colonize for up to 7 days. Medium was changed every day. At the end point the cancer cells 
colonizing the omentum were imaged with an Axio-observer A1 fluorescent microscope 
using 1.25× objective (Carl Zeiss). Thereafter, the omentum pieces were digested with 
Liberase (Roche) and the cancer cell growth was quantified by measuring their fluorescence 
in a plate reader (Synergy HT, BioTek), orcancer cells were isolated by FACS for miR-193b 
qPCR.
Mouse orthotopic xenograft model of OvCa metastasis
The xenograft model was described previously20. Briefly, 1×106 HeyA8 cells either stably 
expressing miR-193b, miR-Zip-193b miR-193b inhibitor, or the respective control 
vectorswere injected intraperitoneally (i.p.) into 6 week old, female, athymic nude mice (10 
mice/group). Mice were euthanized 15 days after infection and the tumors were surgically 
resected and weighed.
Transient transfection
OvCa cells were transfected14 with 30 nM pre-miR-193b, scrambled control oligo 
(Ambion), 30 nM miRCURY LNA anti-miR-193b, or scrambled control LNA oligo 
(Exiqon) using siPORTNeoFX (Ambion). The cells were used for experiments 48 h after 
transfection or as indicated.
Migration
Transwell Migration assays were conducted using 8 μm pore size inserts (BD, Falcon). GFP-
expressing OvCa cells transfected with pre- or anti-miR-193b were added to the upper 
chamber in 200 μl DMEM and allowed to migrate for 3 h at 37°C. DMEM with 10% FBS 
was used as a chemoattractant in the lower chamber. Cells were fixed in 4% 
paraformaldehyde and imaged (5 fields/insert) using an Axio-observer A1 fluorescent 
microscope (Carl Zeiss).
Colony formation
OvCa cells were seeded in 6 well plates (HeyA8, 500 cells/well;Skov3ip1, 2000 cells/well) 
and allowed to form colonies. Once visible colonies were formed (HeyA8, 2 weeks; 
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Skov3ip1, 3 weeks), they were fixed with 4% paraformaldehyde and stained with 0.005% 
crystal violet and were imaged using a SyngeneG:Box imaging system and the number of 
colonies/well were counted.
Invasion through 3D culture
Cellular invasion through the surface of the omentum was assayed in vitro by first 
assembling the 3D culture on 8 μm pore size Fluoroblocktranswell inserts in 24 well plates. 
GFP-expressing OvCa cells were then seeded on the 3D culture in the transwell insert in 200 
μl serum-free DMEM. DMEM with 10% FBS served as a chemoattractant in the lower 
chamber. Cells were allowed to invade for 16 h and then were fixed with 4% 
paraformaldehyde. The fluorescent cancer cells that had invaded were imaged (5 fields/
insert) using an Axio-observer A1 fluorescent microscope (Carl Zeiss).
Adhesion to 3D culture
Cellular adhesion to the surface of the omentum was assayed in vitro by first assembling the 
3D culture in dark 96 well plates with clear bottoms. OvCa cells expressing GFP were 
seeded on the 3D culture and allowed to adhere for 1 h. Total fluorescence in each well was 
measured using a Synergy HT plate reader (BioTek) (excitation, 490 nm; emission, 520 nm) 
and then the wells were washed 3 times with PBS before the fluorescence of the adherent 
cells was measured again. Adherent cells were quantified by normalizing their fluorescence 
to the total fluorescence.
Immunohistochemistry
Immunohistochemical studies were performed by using 5μm thick formalin-fixed 
deparaffinized sections as previously described20, 21. Xenograft tumor tissue was probed 
with anti-Ki-67 (1:300)(Thermo Scientific, SP6), and anti-cleaved caspase 3 (1:100) (Cell 
Signaling, Asp175) antibodies.
Immunoblotting
Immunoblotting was done as previously described 20. Briefly, proteins were separated by 
4-20% gradient SDS-PAGE and transferred to nitrocellulose, probed with anti-uPA antibody 
(American Diagnostica, HD-UK1) and detected using a HRP-linked anti-mouse IgG 
secondary antibody (Cell Signaling, Cat#7076).
Luciferase Assay
3′UTR luciferase reporter assay was performed as described previously14. Briefly, 293T 
cells were co-transfected with a firefly luciferase construct (5 ng) containing the wild type 
PLAU 3′-UTR (SwitchGear Genomics, Menlo Park, CA) or the PLAU 3′-UTR mutated at 
miR-193b seed sequence, along with 10 nM pre-miR-193b or scrambled oligo, using 
Lipofectamine 2000 (Invitrogen). Mutations at the seed sequence of hsa-miR-193b in the 3′-
UTR of PLAU were made using Quick Change Lightning mutagenesis kit (Stratagene) 
according to the manufacturer's protocol. Luciferase activity was measured using a 
LightSwitch Luciferase Assay Kit (SwitchGear Genomics) and read on a BioTek Synergy 
H1 plate reader.
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Statistics
Data analysis was done by unpaired, two-tailed Student's t-test assuming equal variance of 
the test and the control populations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We want to thank Dr. A.F. Haney for collecting omental biopsies, Dr. Abir Mukherjee for helpful discussions, and 
G. Isenberg for carefully editing the manuscript (all at the University of Chicago, Department of Obstetrics and 
Gynecology). We are indebted to all the patients, resident and attending physicians in the Department of Obstetrics 
and Gynecology at the University of Chicago for their participation in tissue collection for these experiments. This 
research was supported by a Marsha Rivkin Pilot Award (AKM) and by National Cancer Institute R01 CA111882 
and RO1 CA169604 grants (EL), and an Ovarian Cancer Research Fund Program Project Development Grant (EL, 
MEP).
References
1. Vaughan S, Coward JI, Bast RC Jr, Berchuck A, Berek JS, Brenton JD, et al. Rethinking ovarian 
cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011; 11:719–725. [PubMed: 
21941283] 
2. Bast RC Jr, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. 
Nat Rev Cancer. 2009; 9:415–428. [PubMed: 19461667] 
3. Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010; 177:1053–1064. 
[PubMed: 20651229] 
4. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic 
sites. Nat Rev Cancer. 2002; 2:563–572. [PubMed: 12154349] 
5. Kenny HA, Chiang CY, White EA, Schryver EM, Habis M, Romero IL, et al. Mesothelial cells 
promote early ovarian cancer metastasis through fibronectin secretion. J Clin Invest. 2014; 
124:4614–4628. [PubMed: 25202979] 
6. Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012; 482:347–355. [PubMed: 
22337054] 
7. Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks. Nat 
Cell Biol. 2013; 15:546–554. [PubMed: 23728460] 
8. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by 
microRNA-10b in breast cancer. Nature. 2007; 449:682–688. [PubMed: 17898713] 
9. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, et al. The microRNAs miR-373 and 
miR-520c promote tumour invasion and metastasis. Nat Cell Biol. 2008; 10:202–210. [PubMed: 
18193036] 
10. Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J, et al. MicroRNA-374a activates Wnt/beta-catenin 
signaling to promote breast cancer metastasis. J Clin Invest. 2013; 123:566–579. [PubMed: 
23321667] 
11. Song SJ, Poliseno L, Song MS, Ala U, Webster K, Ng C, et al. MicroRNA-Antagonism Regulates 
Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling. Cell. 
2013; 154:311–324. [PubMed: 23830207] 
12. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND. MicroRNA-mediated 
integration of haemodynamics and Vegf signalling during angiogenesis. Nature. 2010; 464:1196–
1200. [PubMed: 20364122] 
13. Lwin T, Zhao X, Cheng F, Zhang X, Huang A, Shah B, et al. A microenvironment-mediated c-
Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas. J Clin Invest. 
2013; 123:4612–4626. [PubMed: 24216476] 
Mitra et al. Page 11
Oncogene. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
14. Mitra AK, Zillhardt M, Hua Y, Tiwari P, Murmann AE, Peter ME, et al. MicroRNAs reprogram 
normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov. 2012; 
2:1100–1108. [PubMed: 23171795] 
15. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor 
microenvironment. Cancer Cell. 2012; 21:309–322. [PubMed: 22439926] 
16. Kenny HA, Krausz T, Yamada SD, Lengyel E. Use of a novel 3D culture model to elucidate the 
role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of 
ovarian cancer cells to the omentum. Int J Cancer. 2007; 121:1463–1472. [PubMed: 17546601] 
17. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, et al. Genomic and epigenetic 
alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad 
Sci U S A. 2008; 105:7004–7009. [PubMed: 18458333] 
18. Niedbala MJ, Crickard K, Bernacki RJ. Interactions of human ovarian tumor cells with human 
mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell 
adhesion and invasion. Exp Cell Res. 1985; 160:499–513. [PubMed: 3899694] 
19. Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M, et al. Ovarian cancer 
spheroids use myosin-generated force to clear the mesothelium. Cancer Discov. 2011; 1:144–157. 
[PubMed: 22303516] 
20. Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, Lengyel E. Ligand-independent activation of c-
Met by fibronectin and alpha (5) beta (1)-integrin regulates ovarian cancer invasion and metastasis. 
Oncogene. 2011; 30:1566–1576. [PubMed: 21119598] 
21. Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, et al. Loss of E-cadherin 
promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res. 
2008; 68:2329–2339. [PubMed: 18381440] 
22. Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 
2013; 14:475–488. [PubMed: 23800994] 
23. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005; 74:481–
514. [PubMed: 15952895] 
24. Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, Konik E, et al. Increased expression of 
matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is 
associated with progression from benign to advanced ovarian cancer. Clin Cancer Res. 2001; 
7:2396–2404. [PubMed: 11489818] 
25. Wang L, Madigan MC, Chen H, Liu F, Patterson KI, Beretov J, et al. Expression of urokinase 
plasminogen activator and its receptor in advanced epithelial ovarian cancer patients. Gynecol 
Oncol. 2009; 114:265–272. [PubMed: 19450871] 
26. Zhang Y, Kenny HA, Swindell EP, Mitra AK, Hankins PL, Ahn RW, et al. Urokinase plasminogen 
activator system-targeted delivery of nanobins as a novel ovarian cancer therapy. Mol Cancer Ther. 
2013; 12:2628–2639. [PubMed: 24061648] 
27. Duffy MJ. The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des. 
2004; 10:39–49. [PubMed: 14754404] 
28. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, et al. A pleiotropically 
acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009; 137:1032–1046. 
[PubMed: 19524507] 
29. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 
2011; 147:275–292. [PubMed: 22000009] 
30. Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, et al. Serpins promote cancer cell 
survival and vascular co-option in brain metastasis. Cell. 2014; 156:1002–1016. [PubMed: 
24581498] 
31. White EA, Kenny HA, Lengyel E. Three-dimensional modeling of ovarian cancer. Adv Drug Deliv 
Rev. 2014
32. Rauhala HE, Jalava SE, Isotalo J, Bracken H, Lehmusvaara S, Tammela TL, et al. miR-193b is an 
epigenetically regulated putative tumor suppressor in prostate cancer. Int J Cancer. 2010; 
127:1363–1372. [PubMed: 20073067] 
Mitra et al. Page 12
Oncogene. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
33. Gao XN, Lin J, Gao L, Li YH, Wang LL, Yu L. MicroRNA-193b regulates c-Kit proto-oncogene 
and represses cell proliferation in acute myeloid leukemia. Leuk Res. 2011; 35:1226–1232. 
[PubMed: 21724256] 
34. Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J, et al. MicroRNA-193b regulates proliferation, migration and 
invasion in human hepatocellular carcinoma cells. Eur J Cancer. 2010; 46:2828–2836. [PubMed: 
20655737] 
35. Li XF, Yan PJ, Shao ZM. Downregulation of miR-193b contributes to enhance urokinase-type 
plasminogen activator (uPA) expression and tumor progression and invasion in human breast 
cancer. Oncogene. 2009; 28:3937–3948. [PubMed: 19701247] 
36. Lee JY, Jeong W, Lim W, Lim CH, Bae SM, Kim J, et al. Hypermethylation and post-
transcriptional regulation of DNA methyltransferases in the ovarian carcinomas of the laying hen. 
PLoS One. 2013; 8:e61658. [PubMed: 23613894] 
37. Samudio-Ruiz SL, Hudson LG. Increased DNA methyltransferase activity and DNA methylation 
following Epidermal Growth Factor stimulation in ovarian cancer cells. Epigenetics. 2012; 7:216–
224. [PubMed: 22430797] 
38. Ahluwalia A, Hurteau JA, Bigsby RM, Nephew KP. DNA methylation in ovarian cancer. II. 
Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial 
cells. Gynecol Oncol. 2001; 82:299–304. [PubMed: 11531283] 
39. Noh H, Hong S, Dong Z, Pan ZK, Jing Q, Huang S. Impaired MicroRNA Processing Facilitates 
Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator Expression. 
Genes Cancer. 2011; 2:140–150. [PubMed: 21779487] 
40. Xie C, Jiang XH, Zhang JT, Sun TT, Dong JD, Sanders AJ, et al. CFTR suppresses tumor 
progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. 
Oncogene. 2013; 32:2282–2291. 2291 e2281–2287. [PubMed: 22797075] 
41. Tang CH, Hill ML, Brumwell AN, Chapman HA, Wei Y. Signaling through urokinase and 
urokinase receptor in lung cancer cells requires interactions with beta1 integrins. J Cell Sci. 2008; 
121:3747–3756. [PubMed: 18940913] 
42. Konecny G, Untch M, Pihan A, Kimmig R, Gropp M, Stieber P, et al. Association of urokinase-
type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian 
cancer. Clin Cancer Res. 2001; 7:1743–1749. [PubMed: 11410515] 
43. Zhang W, Ling D, Tan J, Zhang J, Li L. Expression of urokinase plasminogen activator and 
plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance. Oncol Rep. 
2013; 29:637–645. [PubMed: 23174953] 
44. Nieman KM, Romero IL, Van Houten B, Lengyel E. Adipose tissue and adipocytes support 
tumorigenesis and metastasis. Biochim Biophys Acta. 2013; 1831:1533–1541. [PubMed: 
23500888] 
45. Brader KR, Wolf JK, Hung MC, Yu D, Crispens MA, van Golen KL, et al. Adenovirus E1A 
expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents 
through an apoptotic mechanism. Clin Cancer Res. 1997; 3:2017–2024. [PubMed: 9815592] 
46. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. 
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat 
Med. 2011; 17:1498–1503. [PubMed: 22037646] 
Mitra et al. Page 13
Oncogene. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. miR-193b is the most downregulated miRNA in metastasizing OvCa cells
(a) Schematic representation of a human orthotopic 3D culture model mimicking the surface 
layers of the omentum. GFP-expressing OvCa cells were grown on the 3D culture for 2 days 
and then separated by FACS. RNA isolated from these OvCa cells was used for miRNA 
array analysis to determine the deregulated miRNAs during early metastatic colonization. 
(b) miRNA array. Shown is a list of significantly downregulated miRNAs which were sorted 
according to the fold-change in expression. (c) qRT-PCR validation of miR-193b expression 
in HeyA8 and Skov3ip1 OvCa cells seeded on the 3D culture or on mesothelial cells 
(HPMCs) (mean±SD; 3 independent experiments). (d) HeyA8 cells stably expressing GFP 
were seeded on pieces of full human omentum and cultured ex vivo for 2 or 7 days. The 
omentum pieces were digested, fluorescent cancer cells separated by FACS and miR-193b 
expression was quantified by qRT-PCR (mean±SD; 3 independent experiments). (e) qRT-
PCR for miR-193b expression in paired omental metastasis and adjacent (Adj.) normal 
omentum from 7 high grade serous OvCa patients (mean±SD, 3 replicates, * p<0.01, 
**p<0.05, Student's t test).
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Figure 2. miR-193b inhibits motility and growth of ovarian cancer cells
(a-d) miR-193b stable overexpression. (a) Colony formation. HeyA8 cells stably expressing 
miR-193b or vector controls were seeded in 6 well plates for a colony formation assay. 
Colonies were fixed after 2 weeks, stained and counted (mean ± SD; 3 independent 
experiments). (b) Migration. HeyA8 cells stably expressing miR-193b or control vector were 
seeded on 8 μm pore size inserts and allowed to migrate towards medium containing 10% 
FB. Migrated cells were fixed, imaged and quantified (mean±SD; 3 independent 
experiments). (c) Adhesion. HeyA8 GFP cells stably expressing miR-193b or control vector 
were seeded on the 3D culture model and allowed to adhere for 1 hour and quantified using 
a fluorescent plate reader (mean±SD; 3 independent experiments). (d) Invasion. HeyA8 GFP 
cells stably expressing miR-193b were allowed to invade through the 3D culture assembled 
in the upper chamber of 8 μm pore transwell inserts to assess their ability to invade through 
the surface of the omentum. The invaded HeyA8GFP cells were imaged and quantified 
(mean±SD; 3 independent experiments). (e-f) miR-193b inhibition. (e) Colony formation. 
HeyA8 cells were transfected with anti-miR-193b or negative control oligomers and a 
colony formation assay performed as described in (a) (mean±SD; 3 independent 
experiments). (f) Migration. HeyA8 cells were transfected with anti-miR-193b and used in a 
transwell migration assay (mean±SD; 3 independent experiments). * p<0.01, Students t test.
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Figure 3. miR-193b inhibits ovarian cancer cells metastasis
(a) Ex vivo omental assay. HeyA8 cells stably expressing GFP and miR-193b or control 
vector were seeded on pieces of full, freshly removed, human omentum and cultured ex vivo 
for 7 days. The growth of GFP-expressing cells overexpressing miR-193b or control vector 
on the pieces of omentum were imaged with a fluorescent microscope (top) and quantified 
on a fluorescent plate reader after enzymatic digestion of the tissue (right). Representative 
images of Hematoxylin and Eosin staining of omental sections (bottom)(mean±SD; 2 
independent experiments with 3 replicates) (b) Xenograft mouse model of metastasis. 
Female athymic nude mice were injected i.p. with 1×106 HeyA8 cells stably expressing 
miR-193b or the vector control (10 mice per group). Mice were euthanized after 15 days and 
the tumors surgically resected and weighed. Left: Quantification of the tumor weight of 
HeyA8 tumors stably expressing miR-193b compared to control vector. The mean tumor 
weights are indicated and marked by dashes. Right:The tumor sections (n=3) were stained 
for Ki-67 and cleaved (Cl.) caspase 3 expression to test for proliferation and apoptosis, 
respectively. (c) HeyA8 cells (1×106) stably expressing miR-193b inhibitor miR-
Zip-193b(Anti-miR-193b) or control vector were injected i.p. in female athymic nude mice 
(n=10/group). Mice were euthanized after 15 days and the tumors surgically resected and 
weighed. Quantification of the tumor weight of HeyA8 tumors stably expressing miR-
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Zip-193b(Anti-miR-193b) compared to control vector is plotted. The mean tumor weights 
are indicated and marked by dashes. * p<0.01, Students t test.
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Figure 4. miR-193b is downregulated by promoter hypermethylation induced by the interaction 
of ovarian cancer cells with mesothelial cells
(a) Northern blot analysis of the primary transcript of miR-193b (pri-miR-193b) in HeyA8 
cells seeded on the 3D culture or on plastic culture dishes. U6B served as loading control. 
Quantification of the northern blots normalized to U6B using Image J (mean±SD; 2 
independent experiments). (b) qRT-PCR for miR-193b expression in HeyA8 cells pre-
treated with 1 μM 5-Aza-2′ deoxycitidine (5-Aza-2′ dC) for 2 days prior to seeding them on 
the 3D culture model or on mesothelial cells (HPMC). Controls were treated with DMSO. 
The GFP-expressing cancer cells were sorted by FACS following 2 days of co-culture and 
RNA was isolated for qRT-PCR(mean±SD; 3 independent experiments). (c) qRT-PCR for 
miR-193b expression. HeyA8 cells were transfected with DNMT1 siRNA or scrambled 
control oligomer and 24h later the cells were seeded on the 3D culture model (control, 
plastic). After 48 hours on 3D culture, HeyA8 cells were sorted by FACS and miR-193b 
expression in these cells detected by qRT-PCR (mean±SD; 3 independent experiments). (d) 
Proliferation. HeyA8 cells stably expressing GFP were transfected with either DNMT1 
siRNA or anti-miR-193b, transfected with both together, or transfected with equimolar 
amounts of scrambled control oligomers. The cells were used 24h later in a proliferation 
assay measuring the change in green fluorescence every 24 hours or (e) in a migration assay 
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through 8 μm pore inserts(mean±SD; 3 independent experiments). * p<0.01, ** p<0.05, 
Students t test.
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Figure 5. miR-193b inhibits metastatic colonization of ovarian cancer cells through its target, 
uPA
(a) Immunoblot for uPA expression in HeyA8 and Skov3ip1 cells that were seeded on the 
3D culture or on plastic dishes. (b) Immunoblot for uPA in (left) HeyA8 cells transiently 
transfected with pre-miR-193b or scrambled control oligomer or (right) HeyA8 cells stably 
expressing miR-Zip-193b(Anti-miR-193b) or control vector. Immunoblots are representative 
of 3 independent experiments. (c) 3′UTR luciferase reporter assay for the binding of 
miR-193b to the 3′UTR of uPA. Wild type (WT) or miR-193b seed match mutated (Mut) 
uPA 3′UTR luciferase constructs were co-transfected with pre-miR-193b or scrambled 
control (Scr) in 293 T cells and the luciferase activity was measured (mean±SD; 3 
independent experiments). (d) Colony formation. HeyA8 cells were transiently transfected 
with siRNA against uPA or with scrambled control oligomer and seeded for colony 
formation, (e) Migration. HeyA8 cells transfected with uPA siRNA were seeded on 8 μm 
pore inserts for transwell migration. (f) Invasion. uPA was transiently silenced in GFP-
expressing HeyA8 cells and allowed to invade through the 3D culture assembled in the 
upper chamber of 8 μm pore inserts. The invaded HeyA8 GFP cells were imaged and 
quantified. (g) Adhesion. GFP-expressing HeyA8 cells transiently transfected with uPA 
siRNA were allowed to adhere to the 3D culture in 96 well plates for 1 hour and the 
adherent cells were quantified using a fluorescent plate reader (h) Rescue of miR-193b 
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inhibition effects: HeyA8 cells were transfected either with anti-miR-193b or uPA siRNA, 
both together, or with equimolar scrambled control oligomers and used in a trans-well 
migration assay. Error bars represent mean±SD of three independent experiments (* p<0.01, 
Students t test). (i) Proposed model. Interaction of metastasizing OvCa cells with 
mesothelial cells covering the omentum results in a DNMT1-mediated downregulation of 
miR-193b by methylation promoting metastasis through an induction of uPA expression.
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